Skip to main
TRLV

TRLV Stock Forecast & Price Target

TRLV Analyst Ratings

Based on 1 analyst ratings
Buy
Strong Buy 0%
Buy 100%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Trulieve Cannabis is well-positioned for future growth with expanded operations in Texas and Georgia offsetting seasonal pressures in Florida. The company's leadership is optimistic about the potential for further expansion and has diversified its product portfolio to appeal to a wide range of customers. While there are regulatory risks, Trulieve's dominant market share and strong profitability make it a smart investment choice.

Bears say

Trulieve Cannabis is poised for growth with relationships established with 18 of the ~35 independent pharmacies and over 125 expressing interest in their licensed markets, and over 600 authorized physicians to distribute their expanded product line in Florida in spite of seasonal declines in demand in the warmer months. Additionally, the conditional expansion of their fully vertically integrated facility license in Texas should lead to significant market share increases once regulations are finalized for one of the most attractive markets in the U.S.

TRLV has been analyzed by 1 analysts, with a consensus rating of Buy. 0% of analysts recommend a Strong Buy, 100% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Trulieve Cannabis Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Trulieve Cannabis Corp (TRLV) Forecast

Analysts have given TRLV a Buy based on their latest research and market trends.

According to 1 analysts, TRLV has a Buy consensus rating as of Aug 10, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $15, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $15, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Trulieve Cannabis Corp (TRLV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.